Literature DB >> 28823991

Focal precentral gyrus involvement in osmotic demyelination.

Martin R Turner1, John Jacob1,2, Lucy Matthews3, Fintan Sheerin3.   

Abstract

Entities:  

Keywords:  biochemistry; magnetic resonance imaging; metabolic disease; motor neuron disease; neuroanatomy

Year:  2017        PMID: 28823991      PMCID: PMC5629936          DOI: 10.1136/practneurol-2017-001682

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


× No keyword cloud information.

The case

A previously well 59-year-old woman was admitted to a regional hospital with subacute encephalopathy and found to have severe hyponatraemia (101 mmol/L). She had taken indapamide for hypertension over the preceding 3 months. Before referral to neurological services, she had received intravenous hypertonic saline. Her serum sodium concentration normalised within a few days, but was associated with a deteriorating conscious level. She was referred to our tertiary neurological centre with suspected osmotic demyelination where she presented in a ‘locked in’ state, involving quadriplegia and absent vertical eye movements. MR scan of the brain showed typical symmetrical pontine and basal ganglia changes, but also focal hyperintensity of the precentral gyri (figure 1). Nearly 6 months after the initial admission to hospital, the patient had made some recovery of limb strength, but with persistent loss of fine dexterity and unable to stand independently.
Figure 1

MR scan of the brain. Axial fluid-attenuated inversion recovery (FLAIR) images show symmetrical pontine (A), basal ganglia (B) and a ‘ribbon’ of cortical T2 hyperintensity in the posterior precentral gyri (C). The precentral gyral changes are strikingly similar to a focal pattern of MRI changes described in cases of amyotrophic lateral sclerosis.

MR scan of the brain. Axial fluid-attenuated inversion recovery (FLAIR) images show symmetrical pontine (A), basal ganglia (B) and a ‘ribbon’ of cortical T2 hyperintensity in the posterior precentral gyri (C). The precentral gyral changes are strikingly similar to a focal pattern of MRI changes described in cases of amyotrophic lateral sclerosis. Hyponatraemia secondary to thiazide diuretics is well recognised, and cautious correction of chronic hyponatraemia is generally advised to minimise the risk of osmotic demyelination. This unusual extension of MRI changes in extrapontine myelinolysis is uncommon,1 and our case also shared the bilateral hyperintensity in the posterolateral nuclei of the thalami. The strikingly selective involvement of the posterior border of the precentral gyrus is more commonly described in cases of amyotrophic lateral sclerosis in relation to upper motor neurone degeneration,2 3 where iron deposition has been inferred. Corticospinal tract MRI white matter changes occurring in patients with fulminant hepatic failure also overlap in their appearance with those seen in cases of amyotrophic lateral sclerosis.4 These observations might reflect a hitherto unrecognised selective anatomical connectivity of subcortical structures with this region of the motor cortex, or a shared focal metabolic susceptibility.
  4 in total

1.  Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images.

Authors:  Martin J Hecht; F Fellner; C Fellner; M J Hilz; B Neundörfer; D Heuss
Journal:  J Neurol Sci       Date:  2002-07-15       Impact factor: 3.181

2.  Reversible diffusion MRI abnormalities and transient mutism after liver transplantation.

Authors:  Martin R Turner
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

3.  Newly described additional sites of extrapontine myelinolysis along with typical pontine and extrapontine myelinolysis.

Authors:  Kamble Jayaprakash Harsha; K Parameswaran
Journal:  Neurol India       Date:  2017 Jan-Feb       Impact factor: 2.117

4.  Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis.

Authors:  M Costagli; G Donatelli; L Biagi; E Caldarazzo Ienco; G Siciliano; M Tosetti; M Cosottini
Journal:  Neuroimage Clin       Date:  2016-05-02       Impact factor: 4.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.